Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease

BACKGROUND: Diabetes is the commonest cause of chronic kidney disease (CKD). Both conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes and CKD make glucose‐lowering challenging, increasing the risk of hypoglycaemia. Glucose‐lowering agents have been mainly studied...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cochrane Database Syst Rev
Päätekijät: Lo, Clement, Toyama, Tadashi, Wang, Ying, Lin, Jin, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel M, Pilmore, Helen, Badve, Sunil V, Perkovic, Vlado, Zoungas, Sophia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2018
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513625/
https://ncbi.nlm.nih.gov/pubmed/30246878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011798.pub2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia